Intellipharmaceutics Files Shelf Registration

Intellipharmaceutics International Inc. (NASDAQ: IPCI today announced that it intends to offer units of its common shares and warrants in an underwritten public offering. Maxim Group LLC is acting as sole book-running manager for the offering. Brean Capital, LLC is acting as co-manager for the offering. While the offering is expected to price before 9:30 am EDT on July 26, 2013, the offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. A shelf registration statement relating to the public offering of the securities described above has been filed with, and declared effective by, the Securities and Exchange Commission ("SEC"). A preliminary prospectus supplement relating to the offering will be filed with the SEC and will be available on the SEC's website at http://www.sec.gov. When available, copies of the preliminary prospectus supplement and the accompanying base prospectus relating to these securities may also be obtained from Maxim